YN001-004 in Patients With Coronary Atherosclerosis in Australia

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
This study is to evaluate the efficacy and safety of intravenously administered YN001 in patients with coronary atherosclerosis in Australia. This study will be conducted in eligible participants with a diagnosis of coronary atherosclerosis, and at least 1 coronary artery is blocked determined by coronary computed tomography angiography (CCTA)
Epistemonikos ID: b4b495eb5fa5b2976c5acac4204328cb3b370425
First added on: Dec 01, 2024